KRAS and neoplasm: In the case of lung-specific oligometastatic CRC, analysis of primary and metastatic tumors reveals a decrease in the tumor mutation burden (TMB), regressive mutations in K-Ras, and SMAD4, and scarce T cell infiltrate.